General American Investors CO Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

General American Investors CO Inc

  • $1.43 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$65.78 - $105.02 $2.96 Million - $4.73 Million
-45,000 Closed
0 $0
Q2 2020

Aug 03, 2020
SELL
$29.01 - $74.23 $580,200 - $1.48 Million
-20,000 Reduced 30.77%
45,000 $3.29 Million
Q1 2020

May 01, 2020
BUY
$27.51 - $57.29 $1.79 Million - $3.72 Million
65,000 New
65,000 $2.21 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track General American Investors CO Inc Portfolio

Follow General American Investors CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General American Investors CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on General American Investors CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email